Use Of A Genetic Modification In The Human Gnaq Gene For Predicting Risk Of Disease, The Course Of Disease, And Reaction To Treatments
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jan 24, 2008
app pub date -
May 25, 2005
filing date -
May 26, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
In order to determine the risk of disease, the course of a disease, the action of medicaments, the side-effects of medicaments and drug targets, a base substitution is identified in the non-translated region 5' of the gene for the G.alpha.q sub-unit of human G proteins, preferably the presence of two or three of the polymorphisms GC(-909/-908)TT, G(-382)A or G(-387)A being detected.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully